Magnus Althage

594 total citations
23 papers, 371 citations indexed

About

Magnus Althage is a scholar working on Molecular Biology, Public Health, Environmental and Occupational Health and Surgery. According to data from OpenAlex, Magnus Althage has authored 23 papers receiving a total of 371 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 6 papers in Public Health, Environmental and Occupational Health and 3 papers in Surgery. Recurrent topics in Magnus Althage's work include ATP Synthase and ATPases Research (6 papers), Biochemical and Molecular Research (5 papers) and Pregnancy-related medical research (4 papers). Magnus Althage is often cited by papers focused on ATP Synthase and ATPases Research (6 papers), Biochemical and Molecular Research (5 papers) and Pregnancy-related medical research (4 papers). Magnus Althage collaborates with scholars based in Sweden, United Kingdom and United States. Magnus Althage's co-authors include Jan Rydström, Maria Chiara Magnone, Tania Bizouarn, Ryan Hicks, Peter J. Greasley, Christine Ahlström, Phil Ambery, Ian B. Wilkinson, Ralph Knöll and Jeffery A. Engelhardt and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Biochemistry.

In The Last Decade

Magnus Althage

22 papers receiving 367 citations

Peers

Countries citing papers authored by Magnus Althage

Since Specialization

Citations

This map shows the geographic impact of Magnus Althage's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Magnus Althage with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Magnus Althage more than expected).

Fields of papers citing papers by Magnus Althage

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Magnus Althage. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Magnus Althage. The network helps show where Magnus Althage may publish in the future.

Co-authorship network of co-authors of Magnus Althage

This figure shows the co-authorship network connecting the top 25 collaborators of Magnus Althage. A scholar is included among the top collaborators of Magnus Althage based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Magnus Althage. Magnus Althage is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	RXFP1, the relaxin receptor: Lost and found in translation 2025 ·Drug Discovery Today ·Mark Lal, Sean Eddy, Anna Walentinsson, Jeffrey B. Hodgin, (unknown), Magnus Althage, (unknown)	0
2	#1003 Safety, tolerability, pharmacokinetics, and pharmacodynamics of multiple ascending doses of AZD2373, an antisense oligonucleotide targeting APOL1 2024 ·Nephrology Dialysis Transplantation ·Peter J. Greasley, Nikhil Agrawal, Magnus Althage, José Sánchez, Sarah Kirk, (unknown), Magnus Åstrand, (unknown), James Sherwood, Michael McCarthy, Uptal D. Patel, Iain MacPhee	1
3	Identification of Novel Series of Potent and Selective Relaxin Family Peptide Receptor 1 (RXFP1) Agonists 2024 ·Journal of Medicinal Chemistry ·Kenneth L. Granberg, Shigeki Sakamaki, (unknown), (unknown), Masakazu Fujio, (unknown), Fredrik Bergström, Niklas Larsson, Mikael Persson, Inmaculada Concepción Villar, T Fujita, (unknown), Magnus Althage, (unknown), Yoshito Yokoyama, Junpei Kimura, Mark Lal, (unknown)	4
4	Novel Relaxin Receptor RXFP1 Agonist AZD3427 in the Treatment of Heart Failure: A Phase 1a/b, First‐in‐Human, Randomized, Single‐Blind, Placebo‐Controlled Study 2024 ·Journal of the American Heart Association ·(unknown), Richard T. De George, Sami A. Omar, (unknown), Magnus Åstrand, Magnus Althage, Daniel Pettersen, (unknown), (unknown), João A.C. Lima, (unknown), (unknown), (unknown), Petra Johannesson, Anders Gabrielsen, Marcin Ufnal	4
5	3D vascularised proximal tubules-on-a-multiplexed chip model for enhanced cell phenotypes 2023 ·Lab on a Chip ·Miguel Carracedo, Sanlin S. Robinson, (unknown), Maryam Clausen, Ryan Hicks, Graham Belfield, Magnus Althage, Annette Bak, Jennifer A. Lewis, (unknown), Julie M. Williams	14
6	Efficacy and safety of zibotentan and dapagliflozin in patients with chronic kidney disease: study design and baseline characteristics of the ZENITH-CKD trial 2023 ·Nephrology Dialysis Transplantation ·Hiddo J.L. Heerspink, Peter J. Greasley, Christine Ahlström, Magnus Althage, Jamie P. Dwyer, Gordon Law, (unknown), (unknown), (unknown), Mikael Sunnåker, (unknown), David C. Wheeler, Phil Ambery	16
7	Safety, tolerability, and pharmacokinetics of AZD5462, a small molecule agonist of the RXFP1 relaxin receptor 2023 ·European Heart Journal ·Jaya Birgitte Rosenmeier, Katherine Connolly, (unknown), Magnus Åstrand, Magnus Althage, Daniel Pettersen, Alexandra L. Whittaker, Michael Turton, (unknown), A E Gabrielsen	2
8	Endothelin-1 is increased in the plasma of patients hospitalised with Covid-19 2022 ·Journal of Molecular and Cellular Cardiology ·(unknown), Rhoda E. Kuc, Magnus Althage, Peter J. Greasley, Phil Ambery, Janet J. Maguire, Ian B. Wilkinson, Stephen P. Hoole, Joseph Cheriyan, Anthony P. Davenport	28
9	Endothelin antagonism and sodium glucose Co-transporter 2 inhibition. A potential combination therapeutic strategy for COVID-19 2021 ·Pulmonary Pharmacology & Therapeutics ·Marie Fisk, Magnus Althage, Sven Moosmang, Peter J. Greasley, Andrew P. Cope, David Jayne, James Galloway, Frances Hall, Ian B. Wilkinson, Phil Ambery, Joseph Cheriyan	10
10	The long noncoding RNA TUNAR modulates Wnt signaling and regulates human β-cell proliferation 2021 ·American Journal of Physiology-Endocrinology and Metabolism ·(unknown), Tanmoy Mondal, Ali M. Tabish, (unknown), Elke Ericson, David M. Smith, Ralph Knöll, Hanne Scholz, Chandrasekhar Kanduri, Björn Tyrberg, Magnus Althage	11
11	Antisense oligonucleotide treatment ameliorates IFN-γ–induced proteinuria in APOL1-transgenic mice 2019 ·JCI Insight ·Mariam Aghajan, Sheri Booten, Magnus Althage, Christopher E. Hart, Anette Ericsson, (unknown), Joseph Ochaba, (unknown), Judith Hartleib, Steven Kuntz, Danielle Gattis, Christine Ahlström, Andrew T. Watt, Jeffery A. Engelhardt, Brett P. Monia, Maria Chiara Magnone, Shuling Guo	69
12	In vivo genome and base editing of a human PCSK9 knock-in hypercholesterolemic mouse model 2019 ·BMC Biology ·Alba Carreras, Luna Simona Pane, Roberto Nitsch, Katja Madeyski-Bengtson, Michelle J. Porritt, Pınar Akçakaya, Amir Taheri‐Ghahfarokhi, Elke Ericson, Mikael Bjursell, Marta Pérez-Alcázar, Frank Seeliger, Magnus Althage, Ralph Knöll, Ryan Hicks, Lorenz M. Mayr, Rosie Perkins, Daniel Lindén, Jan Borén, Mohammad Bohlooly‐Y, Marcello Maresca	64
13	Humanizing Miniature Hearts through 4-Flow Cannulation Perfusion Decellularization and Recellularization 2018 ·Scientific Reports ·(unknown), (unknown), Cecilia Granéli, Ryan Hicks, Tasso Miliotis, Ann‐Christin Nyström, Sara Hansson, Pia Davidsson, Li‐Ming Gan, Maria Chiara Magnone, Magnus Althage, Sepideh Heydarkhan‐Hagvall	30
14	Translational strategy: humanized mini-organs 2018 ·Drug Discovery Today ·(unknown), Magnus Althage, Maria Chiara Magnone, Sepideh Heydarkhan‐Hagvall	6
15	Long noncoding RNAs are dynamically regulated during β-cell mass expansion in mouse pregnancy and control β-cell proliferation in vitro 2017 ·PLoS ONE ·Giorgia Sisino, Alex‐Xianghua Zhou, (unknown), Alan Sabirsh, Mangala M. Soundarapandian, Ranjan J. Perera, (unknown), Maria Chiara Magnone, Magnus Althage, Björn Tyrberg	15
16	Communication between the ERRα Homodimer Interface and the PGC-1α Binding Surface via the Helix 8–9 Loop 2008 ·Journal of Biological Chemistry ·Holger Greschik, Magnus Althage, Ralf Flaig, Yoshiteru Sato, Virginie Chavant, Carole Peluso‐Iltis, Laurence Choulier, Philippe Cronet, Natacha Rochel, Roland Schüle, Per-Erik Strömstedt, Dino Moras	34
17	Cross-linking of transmembrane helices in proton-translocating nicotinamide nucleotide transhydrogenase from Escherichia coli: implications for the structure and function of the membrane domain 2004 ·Biochimica et Biophysica Acta (BBA) - Bioenergetics ·Magnus Althage, Tania Bizouarn, Bert Kindlund, Jonathan G.L. Mullins, (unknown), Jan Rydström	6
18	Properties of the apo-form of the NADP(H)-binding domain III of proton-pumping Escherichia coli transhydrogenase: implications for the reaction mechanism of the intact enzyme 2003 ·Biochimica et Biophysica Acta (BBA) - Bioenergetics ·Anders Pedersen, (unknown), Magnus Althage, Jan Rydström	8
19	Roles of Individual Amino Acids in Helix 14 of the Membrane Domain of Proton-Translocating Transhydrogenase from Escherichia coli As Deduced from Cysteine Mutagenesis 2003 ·Biochemistry ·(unknown), Magnus Althage, Jan Rydström	9
20	The organization of the membrane domain and its interaction with the NADP(H)-binding site in proton-translocating transhydrogenase from E. coli 2002 ·Biochimica et Biophysica Acta (BBA) - Bioenergetics ·Tania Bizouarn, Magnus Althage, Anders Pedersen, (unknown), (unknown), Carina Johansson, Jan Rydström	16

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact